drugset
drugset / Trial / NCT07153146

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of PN-881 in Healthy Subjects.

NCT07153146 ↗

Phase 1 Recruiting 142 enrolled Protagonist Therapeutics, Inc.
RandomizedSequentialDouble-blindTreatment

Summary

The goal of this study is to evaluate the safety, tolerability, pharmacokinetics, and pharmacodynamics of PN-881 in healthy adult participants.

Timeline

Start
2025-10-07
Primary completion
2026-06-15
Completion
2026-06-15

Drugs

EvaluationDrugModalityDoseRoute
Subject PN-881 Unknown — Oral

Indications

No indication recorded.